MMP2 and lung cancer: A previous study showed that miR‐194 can target bone morphogenetic protein 1 (BMP1) and kip1, leading to suppression of transforming growth factor β activity and down‐regulation of the expression of key oncogenic genes such as matrix metalloproteinases MMP2 and MMP9, and thus suppress the metastasis of non‐small cell lung cancer 9.